Nordhealth Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Charles MacBain

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	50.2%
Management average tenure	no data
Board average tenure	2.7yrs

Recent management updates

Recent updates

Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

May 12

Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Jan 25

CEO

Charles MacBain

no data

Tenure

Mr. Charles MacBain serves as Chief Executive Officer of Nordhealth AS.

Board Members

Name	Position	Tenure	Compensation	Ownership
Janne Huttunen	Chief Innovation Officer of Veterinary & Board Member	2.7yrs	no data	3.97% € 80.4m
Philippe Vimard	Director	less than a year	no data	no data
Didier Breton	Chairman of the board	2.7yrs	no data	0.25% € 5.1m

2.7yrs

Average Tenure

Experienced Board: NORDH's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Nordhealth Management

Management criteria checks 0/4

Key information

Recent management updates

Insider recently bought kr462k worth of stock

Chief Executive Officer recently bought kr5.3m worth of stock

Chief Executive Officer recently bought kr13m worth of stock

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2023 earnings released

Insider recently bought kr462k worth of stock

New major risk - Share price stability

Chief Executive Officer recently bought kr5.3m worth of stock

First quarter 2023 earnings released

Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

Chief Executive Officer recently bought kr13m worth of stock

Full year 2022 earnings released

Third quarter 2022 earnings released: €0.043 loss per share (vs €0.009 loss in 3Q 2021)

Nordhealth AS to Report Fiscal Year 2022 Final Results on Apr 14, 2023

Nordhealth AS to Report Q3, 2022 Results on Nov 25, 2022

Less than half of directors are independent

Consensus forecasts updated

Second quarter 2022 earnings released: €0.044 loss per share (vs €0.025 loss in 2Q 2021)

Consensus EPS estimates fall by 55%

Nordhealth AS to Report First Half, 2022 Results on Aug 19, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Nordhealth AS to Report Q1, 2022 Results on May 20, 2022

Less than half of directors are independent

Consensus forecasts updated

Full year 2021 earnings: EPS exceeds analyst expectations

Nordhealth AS to Report Q4, 2021 Results on Mar 08, 2022

Nordhealth AS (OB:NORDH) acquired Easypractice Aps for DKK 110 million

Nordhealth AS (OB:NORDH) acquired Yoma Consulting's Veterinary Software Implementation And Support Business from Yoma Consulting Ab.

Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Consensus EPS estimates fall to -€0.04

Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint

Nordhealth AS (OB:NORDH) acquired Aspit As from Kistefos AS, founders and senior management for approximately NOK 400 million.

CEO

Tenure

Board Members

Average Tenure